Roger Norman Andrews, MD in Arcadia, CA - Urology

Roger Norman Andrews, MD is a Urology physician based in Arcadia, California. Roger Norman Andrews is licensed to practice in California (license number G31944) and his current practice location is 624 W Duarte Rd, Suite 203, Arcadia, California. He can be reached at his office (for appointments etc.) via phone at (626) 446-8595.

NPI number for Roger Norman Andrews is 1922070838 and his current mailing address is 624 W Duarte Rd, Suite 203, Arcadia, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1922070838.

Contact Information

	Roger Norman Andrews, MD
	624 W Duarte Rd, Suite 203, Arcadia, CA 91007-7603
	(626) 446-8595
	(626) 446-1031

Physician's Profile

Full Name	Roger Norman Andrews
Gender	Male
Speciality	Urology
Location	624 W Duarte Rd, Arcadia, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1922070838
Provider Enumeration Date: 02/03/2006
Last Update Date: 08/26/2008

Medical Identifiers

Medical identifiers for Roger Norman Andrews such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922070838	NPI	-	NPPES
00G319440	Medicaid	CA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	G31944 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Roger Norman Andrews is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Roger Norman Andrews, MD 624 W Duarte Rd, Suite 203, Arcadia, CA 91007-7603 Ph: (626) 446-8595	Roger Norman Andrews, MD 624 W Duarte Rd, Suite 203, Arcadia, CA 91007-7603 Ph: (626) 446-8595

News Archive

imec researchers demonstrate biosensors that detect extremely low concentrations of disease markers

Researchers at the nanotechnology research centre imec have demonstrated biosensors based on novel nanostructure geometries that increase the sensitivity and allow to detect extremely low concentrations of specific disease markers. This paves the way to early diagnostics of for example cancer by detecting low densities of cancer markers in human blood samples.

Chindex's new contract financed by KfW Development Bank of Germany

Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced that it has entered into a contract to supply EUR5 million in laboratory and hospital products to Centers for Disease Control in China's Qinghai Province.

Overweight, smoking and lack of exercise linked to frequent headaches in teens

Teens who are overweight, get little exercise or who smoke may be more likely to have frequent headaches and migraines than teens with none of these factors, according to a study published in the August 18, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Patrolling monocytes may play anti-cancer role in the lung

One goal of immunotherapy is to rally a patient's often over-burdened immune cells to effectively attack a tumor. Among foot soldiers on the immune front line is a subpopulation of white blood cells called "patrolling monocytes," whose job is to cruise the bloodstream, cart off cellular debris, and block invasion of a less benign population of inflammatory cells.

Janssen submits canagliflozin NDA with FDA for treatment of type 2 diabetes

Janssen Research & Development, LLC (Janssen), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of adult patients with type 2 diabetes.

Urology Doctors in Arcadia, CA

Alan H Yamada, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 624 W Duarte Rd, Suite 203, Arcadia, CA 91007
Phone: 626-446-8595 Fax: 626-446-1031

Roger Norman Andrews, MD - Urology in Arcadia, CA